Open-Label Clinical Trials of Oral Pulse Dexamethasone for Adults with Idiopathic Nephrotic Syndrome

Background: In adults with primary focal segmental glomerulosclerosis (FSGS), daily prednisone may induce complete remissions (CR) and partial remissions (PR), but relapses are frequent and adverse events are common. Methods: We carried out 2 open-label, uncontrolled trials to explore the efficacy a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of nephrology 2019-01, Vol.49 (5), p.377-385
Hauptverfasser:	Cho, Monique E., Branton, Mary H., Smith, David A., Bartlett, Linda, Howard, Lilian, Reynolds, James C., Rosenstein, Donald, Sethi, Sanjeev, Nava, M. Berenice, Barisoni, Laura, Fervenza, Fernando C., Kopp, Jeffrey B.
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Adult Aged Dexamethasone Dexamethasone - administration & dosage Dexamethasone - adverse effects Drug therapy Female Follow-Up Studies Glomerulosclerosis, Focal Segmental - complications Glomerulosclerosis, Focal Segmental - drug therapy Glomerulosclerosis, Focal Segmental - immunology Humans Immunosuppressive Agents - administration & dosage Immunosuppressive Agents - adverse effects Male Middle Aged Nephrotic syndrome Nephrotic Syndrome - drug therapy Nephrotic Syndrome - immunology Patient-Oriented, Translational Research: Research Article Pulse Therapy, Drug Remission Induction - methods Testing Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!